PREVALENCE OF HEPATITIS C AMONG HEMODIALYSIS PATIENTS IN DIALYSIS UNIT DR. SARDJITO GENERAL HOSPITAL, YOGYAKARTA

Background: Hepatitis C Virus (HCV) infection is common among hemodialysis patients with End stage renal disease (ESRD) and probably occurs through nosocomial infection. Strict infection control measures should be taken and implemented to prevent nosocomial infection. Objective: To determine the ser...

Full description

Bibliographic Details
Main Authors: , KHAUCELLYA RAJAGOPAL, , dr. Didik Setyo Heriyanto, Ph.D, Sp.PA
Format: Thesis
Published: [Yogyakarta] : Universitas Gadjah Mada 2014
Subjects:
ETD
Description
Summary:Background: Hepatitis C Virus (HCV) infection is common among hemodialysis patients with End stage renal disease (ESRD) and probably occurs through nosocomial infection. Strict infection control measures should be taken and implemented to prevent nosocomial infection. Objective: To determine the seroprevalence and risk factors for hepatitis C virus (HCV) infection among patients at Dialysis Unit Dr. Sardjito General Hospital, Yogyakarta. Method: Total 137 patients who come to the hemodialysis unit of Dr. Sardjito Hospital Yogyakarta has been recruited using consecutive sampling method. Serum samples were obtained, centrifuged and tested at Pathology Anatomy Lab of Universitas Gadjah Mada, Yogyakarta. Testing for anti-HCV antibodies was performed at initiation of hemodialysis and every 3�6 months thereafter. Results: Out of 137 patients, 112 were males and 25 were females. The age group varied from 19 to 76 years. The overall anti-HCV antibody prevalence rate among hemodialysis patient was 81,8%. In men the prevalence rate of anti HCV antibody positive (77,8%) was higher compared to negative anti-HCV antibody (22,2%) The prevalence age among the age group 15-29 of positive anti-HCV antibody was 80,0% compared to negative anti- HCV antibody (20,0%). The prevalence of positive anti- HCV antibody among the age group 30-44 years was 85,7% compared to negative anti-HCV antibody (14,3%). It is observed in the age group of 45-59, the prevalence rate of anti-HCV antibody was higher (82,6%) compared to anti-HCV negative (17,4%). Duration of hemodialysis was significantly associated with seropositivity. The duration of hemodialysis less than 1 year had a higher prevalence of anti-HCV positive (67,6%) compared to anti-HCV negative (32,4%). Duration of hemodialysis between 1 year to 3 years had a higher prevalence of anti-HCV positive (81,6) compared to anti-HCV negative (18,4%). The hemodialysis longer than 3 years had a higher prevalence of anti-HCV positive (94,0%) compared to anti-HCV negative(6,0%). Conclusion: Patients in the Dialysis Unit of Dr. Sardjito General Hospital Yogyakarta have a high prevalence of HCV infection. The factors associated with HCV infection are highly suggestive of nosocomial transmission within the hemodialysis units. Imperative action is required to improve infection control measures in hemodialysis centres.